학술논문
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial
Document Type
Article
Author
Abhishek, A.; Valdes, A.M.; Nguyen-Van-Tam, J.S.; Williams, H.C.; Peckham, N.; Cureton, L.; Francis, A.; Barber, V.; Williams, J.A.E.; Appelbe, D.; Eldridge, L.; Julier, P.; Coates, L.C.; Cook, J.A.; Pade, C.; Gibbons, J.M.; McKnight, Á.; Altmann, D.M.; Boyton, R.J.; Bluett, J.; Brooks, T.; Semper, A.; Otter, A.; Rombach, I.; Pande, I.; Tang, T.S.; Tran, G.; Layton, A.; Price, E.; Whittam, L.; Venkatachalam, S.; Huws, G.; Pratt, A.; Reynolds, N.J.; Youngstein, T.; Walsh, D.A.; Joseph, T.; Mathew, R.; Oikonomou, S.; Gwynne, C.; Crowder, R.; Saravanan, V.; Mustafa, A.; Tacu, C.; George, E.; Batty, T.; Soni, A.; Horton, S.; Gaffney, K.; Gullick, N.; Lapin, A.; Bingham, S.; Madan, A.; Holroyd, C.; Lwin, M.; Khalid, S.; Green, M.; Hunt, L.; Alcorn, N.; Ellis, R.; Hider, S.; Hassan, A.; Douglas, K.; Ho, G.N.; Levasseur, K.; Pradeep, J.; Rhys-Dillon, C.; Jones, C.
Source
In: The Lancet Rheumatology . (The Lancet Rheumatology, February 2024, 6(2):e92-e104)
Subject
Language
English
ISSN
26659913